Atricure

Forecast & Rating10 analysts currently cover Atricure, with about 80.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $47.33, about 3.4% downside from the current price of $48.98. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 36.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Atricure closely still see room for the stock to rise. Data as of Aug 11, 2026; for reference only and not investment advice.